 |
 |

Endothelial Cell Density to Predict Endothelial Graft Failure After Penetrating Keratoplasty
Jonathan H. Lass, MD;
Alan Sugar, MD;
Beth Ann Benetz, MA;
Roy W. Beck, MD, PhD;
Mariya Dontchev, MPH;
Robin L. Gal, MSPH;
Craig Kollman, PhD;
Robert Gross, MD;
Ellen Heck, MS, MA;
Edward J. Holland, MD;
Mark J. Mannis, MD;
Irving Raber, MD;
Walter Stark, MD;
R. Doyle Stulting, MD, PhD; for the Cornea Donor Study Investigator Group
Arch Ophthalmol. 2010;128(1):63-69. doi:10.1001/archophthalmol.2010.128.63
Objective To determine whether preoperative and/or postoperative central endothelial cell density (ECD) and its rate of decline postoperatively are predictive of graft failure caused by endothelial decompensation following penetrating keratoplasty to treat a moderate-risk condition, principally, Fuchs dystrophy or pseudophakic corneal edema.
Methods In a subset of Cornea Donor Study participants, a central reading center determined preoperative and postoperative ECD from available specular images for 17 grafts that failed because of endothelial decompensation and 483 grafts that did not fail.
Results Preoperative ECD was not predictive of graft failure caused by endothelial decompensation (P = .91). However, the 6-month ECD was predictive of subsequent failure (P < .001). Among those that had not failed within the first 6 months, the 5-year cumulative incidence (±95% confidence interval) of failure was 13% (±12%) for the 33 participants with a 6-month ECD of less than 1700 cells/mm2 vs 2% (±3%) for the 137 participants with a 6-month ECD of 2500 cells/mm2 or higher. After 5 years' follow-up, 40 of 277 participants (14%) with a clear graft had an ECD below 500 cells/mm2.
Conclusions Preoperative ECD is unrelated to graft failure from endothelial decompensation, whereas there is a strong correlation of ECD at 6 months with graft failure from endothelial decompensation. A graft can remain clear after 5 years even when the ECD is below 500 cells/mm2.
Clinical Trial Registry clinicaltrials.gov Identifier: NCT00006411
Author Affiliations: Department of Ophthalmology and Visual Sciences, Case Western Reserve University and University Hospitals Eye Institute, Cleveland, Ohio (Dr Lass and Ms Benetz); W. K. Kellogg Eye Center, University of Michigan, Ann Arbor (Dr Sugar); Jaeb Center for Health Research, Tampa, Florida (Drs Beck and Kollman and Mss Dontchev and Gal); Cornea Consultants of Arizona, Phoenix (Dr Gross); Transplant Services Center, The University of Texas Southwestern Medical Center at Dallas (Ms Heck); Cincinnati Eye Institute, Cincinnati, Ohio (Dr Holland); Department of Ophthalmology and Vision Science, University of California–Davis, Sacramento (Dr Mannis); Ophthalmic Partners of Pennsylvania, Bala Cynwyd (Dr Raber); The Johns Hopkins University School of Medicine, The Wilmer Ophthalmological Institute, Baltimore, Maryland (Dr Stark); and Department of Ophthalmology, Emory University, Atlanta, Georgia (Dr Stulting).
CiteULike Connotea Delicious Digg Facebook Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Baseline Factors Related to Endothelial Cell Loss Following Penetrating Keratoplasty
Lass et al.
Arch Ophthalmol 2011;129:1149-1154.
ABSTRACT
| FULL TEXT
Pan-Corneal Endothelial Viability Assessment: Application to Endothelial Grafts Predissected by Eye Banks
Pipparelli et al.
IOVS 2011;52:6018-6025.
ABSTRACT
| FULL TEXT
|